Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
The fastest path to regulatory-grade AI is rarely the one that starts from scratch — and rarely the one that hands over control. Here is how mature pharma organizations are doing both.
The Build-vs-Buy Debate Is the Wrong One for Regulatory-Grade AI Read More »
Yseop was recently featured in mind Health, where Pierre-Louis Durel, VP Strategy & Operations, shared how AI is transforming regulatory writing—and why it is becoming a critical lever for accelerating access to new therapies.
Yseop Featured in mind Health: Accelerating Drug Approvals with Regulatory-Grade AI Read More »
The AI transformation underway in life sciences regulatory affairs is understated, yet tangible and grounded. It is a quiet revolution: instead of pursuing speculative intelligence, organizations are applying AI to automate predictable, rules-driven regulatory work.
The Quiet Revolution of AI in Regulatory Affairs Read More »
Why do AI pilots fail to scale in life sciences regulatory teams? Based on our experience supporting AI adoption in regulatory environments worldwide, this article explains what successful teams do differently.
What Does Successful AI Adoption Look Like in Regulatory Affairs? Read More »